10-KPeriod: FY1996

QUEST DIAGNOSTICS INC Annual Report, Year Ended Dec 31, 1996

Filed March 19, 1997For Securities:DGX

Summary

Quest Diagnostics Inc. (DGX) filed its 10-K for the fiscal year ended December 31, 1996, on March 19, 1997. While the provided filing content is primarily navigational metadata and directory listings for the EDGAR system rather than the full financial report, it indicates the company's adherence to SEC reporting requirements. Investors would typically look to the full 10-K filing for critical financial data, management's discussion and analysis of financial condition and results of operations, risk factors, and detailed business segment information. Without the substantive financial and operational details from the 10-K itself, a comprehensive investor-focused analysis is not possible. The metadata confirms the filing's existence and date, suggesting an ongoing commitment to public disclosure for shareholders. Investors are advised to seek the complete filing to assess the company's financial health, strategic direction, and performance in 1996.

Key Highlights

  • 1The filing is Quest Diagnostics Inc.'s (DGX) Annual Report on Form 10-K for the fiscal year ending December 31, 1996.
  • 2The report was officially filed with the SEC on March 19, 1997.
  • 3The provided content consists of EDGAR system navigational links and file directory listings, not the actual financial statements or management discussion.
  • 4This filing signifies Quest Diagnostics' compliance with annual reporting obligations to the U.S. Securities and Exchange Commission.
  • 5Investors would need the full 10-K document to access financial performance, operational details, and strategic insights for 1996.
  • 6The metadata confirms the period covered and the filing date, establishing a timeline for the company's reported performance.

Frequently Asked Questions

This 10-K filing is Quest Diagnostics Inc.'s official annual report to the U.S. Securities and Exchange Commission (SEC) for the fiscal year ending December 31, 1996. It is intended to provide shareholders and potential investors with comprehensive information about the company's financial performance, business operations, risk factors, and management's outlook.

Unfortunately, the provided content is only metadata and navigational links for the EDGAR system. The actual 10-K filing would contain crucial financial statements (income statement, balance sheet, cash flow statement), management's discussion and analysis (MD&A) of financial condition and results of operations, and notes to the financial statements. Investors should refer to the complete 10-K document for this detailed financial data.

The filing date of March 19, 1997, indicates when Quest Diagnostics officially submitted its annual report for the 1996 fiscal year to the SEC. This date is important for understanding the timeliness of the information and for comparing reporting cycles with other companies.

The actual financial data and narrative analysis would be contained within the full 10-K report filed by Quest Diagnostics. You would typically access this through the SEC's EDGAR database or the investor relations section of Quest Diagnostics' corporate website. The provided content is a directory listing and does not contain the substantive report.